-
OPINION: What ‘100 Percent Effective’ Means for That Ebola Vaccine
Lat week, the medical journal the Lancet published preliminary results on the efficacy of an Ebola vaccine in Guinea, and everybody got really excited – especially about one particular figure. The vaccine, the results suggested, was 100 percent effective at protecting against Ebola ... But that number probably means less than you think it does.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Viewpoint: Ebola Vaccine: The Need to Act Now
One year ago West Africa was descending into chaos. As the Ebola death toll approached 1,000 for the first time ever and Liberia closed its borders, the World Health Organization declared the situation an international health emergency. Experimental drugs were cautiously put to use to try to treat those infected, but what was urgently needed to stop the spread was a vaccine. Now, 12 months on, it looks very much like we have one.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Birth Registrations Plummet in Wake of Ebola Epidemic
Liberia’s Ebola epidemic may have subsided but its after-effects are still being felt, with tens of thousands of infants going unregistered at birth, the U.N. children’s agency UNICEF says.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
A Paper Microscope That Costs Only 50 cents Can Detect Malaria From Just a Drop of Blood – And It Could Revolutionize Medicine
For a whole lot of people, especially those in developing countries, science - and with it, medicine - isn't readily available to the majority of citizens. But Manu Prakash wants to change that.
- Categories
- Health Care
-
When ‘Wonder Drugs’ Aren’t Enough: Viral hepatitis reaches watershed moment, but who will pay?
Debate rages about what constitutes fair pricing practices for a lifesaving drug that could save millions of people – and how to balance affordability and access with sustained investment in R&D, company profits and responsiveness to stakeholders including patients, health care providers, payers and shareholders.
- Categories
- Health Care
-
WHO: Unsafe Injections Major Cause of Hepatitis Death
In advance of World Hepatitis Day (July 28), the World Health Organization is calling for urgent action to curb millions of infections and deaths from viral hepatitis.
- Categories
- Health Care
-
Health Specialists Call for $2 Billion Global Fund for Vaccines
Global health experts called on Wednesday for the creation of a $2 billion vaccine development fund to feed a pipeline of potential new shots against priority killer diseases like Ebola, MERS and the West Nile virus.
- Categories
- Health Care
-
Sanofi Preps for ‘Profitable’ Dengue Vaccine Rollout in 20 Countries
With more than $1.5 billion in development costs and 20 years of research on the line, Sanofi ($SNY) is getting revved up to launch its world-first dengue vaccine later this year. And if the company's predictions are correct, the shot will not only be a big deal for patients in the developing world--it'll be a highly profitable product to boot.
- Categories
- Health Care
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.